As the world is set to ring in 2017 in just a few short days, investors are in the process of adjusting their stock picks for the next year, which could potentially see a corporate tax reform, higher interest rates, the repeal of the Affordable Care Act and reduced regulation under the Trump administration.
Apart from the macro factors, company-specific factors are also anticipated to bring a swing of fortunes that may hit the top line.
In this backdrop, Benzinga brings you the list of six stocks with the lowest forecast sales growth. The criteria: trailing 12-month revenue of greater than $20 million. The following list will showcase small- and mid-cap companies expected to generate weaker 2017 sales versus last year, as projected by Wall Street consensus.
Symbol |
Name |
Revenue (TTM) |
Revenue Est. For Current Fiscal Year |
Revenue Est. For Next Fiscal Year |
ATW |
Atwood Oceanics, Inc. ATW |
1.021 billion
|
1.026 billion
|
525.21 million |
CYTK |
Cytokinetics, Inc. CYTK |
83.03 million |
85.04 million |
40.13 million |
NADL |
North Atlantic Drilling Ltd. NADL |
603.30 million |
529.45 million |
236.38 million |
OPHT |
Ophthotech Corp OPHT |
50.37 million |
51.20 million |
8.00 million |
PFNX |
Pfenex Inc PFNX |
57.98 million |
57.20 million |
10.00 million |
UUUU |
Energy Fuels Inc (USA) UUUU |
44.59 million
|
54.45 million |
25.66 million |
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.